AI assistant
Immuron Ltd — Declaration of Voting Results & Voting Rights Announcements 2013
Nov 28, 2013
35121_rns_2013-11-28_f23c3ac8-8b48-4926-bb6a-55b305ee46da.pdf
Declaration of Voting Results & Voting Rights Announcements
Open in viewerOpens in your device viewer
==> picture [192 x 41] intentionally omitted <==
Level 1, 18 Kavanagh Street Southbank, Vic 3006 Tel: +61 (0)3 8648 4530 Fax: +61 (0)3 9686 9460 www.immuron.com ABN: 80 063 114 045
Immuron Limited
(ASX: IMC)
RESULTS OF ANNUAL GENERAL MEETING
Friday 29[th] November 2013
The Company wishes to advise that all resolutions were carried on show of hands.
In accordance with Listing Rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, the following information is provided in relation to the resolutions considered by Members of the Company at the Annual General Meeting held today.
| Resolution | Resolution | For | Against | Abstain | Proxy'sDiscretion* | Total ValidProxiesReceived |
|---|---|---|---|---|---|---|
| 1 | Adoption of Remuneration Report | 238,174,139 | 2,945,786 | 64,492,498 | 169,534,561 | 475,146,984 |
| 2 | Election of Daniel Pollock as a Director | 189,334,855 | 694,481 | 65,583,087 | 219,534,561 | 475,146,984 |
| 3 | Election of Stephen Anastasiou as a Director | 195,752,848 | 695,481 | 109,164,094 | 169,534,561 | 475,146,984 |
| 4 | Approve the issue of 8,750,000 Shares to Grandlodge Pty Ltd | 195,467,295 | 60,145,128 | 168,326,929 | 51,207,632 | 475,146,984 |
| 5 | Approve the issue of 2,604,167 Shares and 20,000,000 Options to Roger Aston | 195,467,295 | 981,034 | 59,164,094 | 219,534,561 | 475,146,984 |
| 6 | Approve the issue of 1,875,000 Shares and 10,000,000 Options to Daniel Pollock | 189,048,302 | 60,145,128 | 6,418,993 | 219,534,561 | 475,146,984 |
| 7 | Approve the issue of 10,000,000 Options to Stephen Anastasiou | 195,467,295 | 60,145,128 | 50,000,000 | 169,534,561 | 475,146,984 |
| 8 | Approve the issue of 5,000,000 Shares and 10,000,000 Options to The CFO Solution | 252,131,389 | 981,034 | 2,500,000 | 219,534,561 | 475,146,984 |
| 9 | Appointment of William Buck Audit (VIC) Pty Ltd as the Company's auditor | 255,279,892 | 238,245 | 94,286 | 219,534,561 | 475,146,984 |
| 10 | Approval of additional capacity to issue Shares under ASX Listing Rule 7.1A | 188,932,387 | 66,680,036 | - | 219,534,561 | 475,146,984 |
- The Chairman voted undirected proxies in his control in favour of all resolutions.
On behalf of the Board
==> picture [80 x 58] intentionally omitted <==
Phillip Hains Company Secretary
About Immuron Limited
Immuron is a biopharmaceutical company focused on oral immunotherapy treatments using dairy-derived antibody products for humans. Immuron is uniquely positioned with a versatile technology platform capable of generating a wide range of products with a high safety profile. This high safety profile makes it possible to complete pre-clinical studies relatively quickly and increases the prospect that the clinical development of Immuron’s products will be expedited. Immuron’s current products and product candidates target infectious diseases of the gastrointestinal tract, chronic diseases such as fatty liver/NASH, and influenza. Immuron has a product in the market, Travelan, for preventing travellers’ diarrhoea.
Page 1 of 1